Serum Gal-9 concentrations have been observed to be significantly increased in patients with infections such as HIV24, hepatitis C virus (HCV)25 and malaria26, suggesting increased gal-9 production is not specific to COVID-19 infection. Here, LGALS9 is linked to infection.